Your browser doesn't support javascript.
loading
Risk perception and disease knowledge in attendees of a community-based lung cancer screening programme.
Lebrett, Mikey B; Crosbie, Emma J; Yorke, Janelle; Hewitt, Kath; Rowlands, Ailsa; Badrick, Ellena; Gareth Evans, D; Balata, Haval; Booton, Richard; Crosbie, Philip A J.
Afiliação
  • Lebrett MB; Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Prevention and Early Detection Theme, NIHR Manchester Biomedical Research Centre, Manchester, UK.
  • Crosbie EJ; Prevention and Early Detection Theme, NIHR Manchester Biomedical Research Centre, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Department of Obstetrics & Gynaecology, St Mary's Hospital, Manchester University NHS
  • Yorke J; Christie Patient Centred Research, The Christie NHS Foundation Trust, Manchester, UK; Division of Nursing, Midwifery and Social Work, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Hewitt K; Manchester Thoracic Oncology Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Rowlands A; Manchester Thoracic Oncology Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Badrick E; Prevention and Early Detection Theme, NIHR Manchester Biomedical Research Centre, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Gareth Evans D; Prevention and Early Detection Theme, NIHR Manchester Biomedical Research Centre, Manchester, UK; Manchester Centre for Genomic Medicine, St Mary's Hospital, Division of Evolution and Genomic Sciences, School of Biological Sciences, University of Manchester, Manchester, UK.
  • Balata H; Manchester Thoracic Oncology Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Booton R; Manchester Thoracic Oncology Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Crosbie PAJ; Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Prevention and Early Detection Theme, NIHR Manchester Biomedical Research Centre, Manchester, UK; Manchester Thoracic Oncology Centre, Wythenshawe Hospital, Ma
Lung Cancer ; 168: 1-9, 2022 06.
Article em En | MEDLINE | ID: mdl-35430354
ABSTRACT

OBJECTIVES:

In England, a risk-based approach is used to determine eligibility for lung cancer screening. Ensuring effective communication and counselling of risk is therefore increasingly important. In this study, we explore the perception of lung cancer risk in attendees of a community-based screening service, located in socio-economically deprived areas of Manchester. We analyse responses based on demographic variables, calculated risk score and screening eligibility. MATERIALS AND

METHODS:

The Manchester Lung Health Check (LHC) programme invited ever smokers, age 55-80, to a lung cancer risk assessment in which their 6-year risk was calculated (using the PLCOM2012 model). Those at high risk (PLCOM2012 score ≥ 1.51%) were eligible for low dose CT (LDCT) screening. Prior to their assessment, attendees were invited to complete the study questionnaire, which assessed absolute and comparative risk perception, disease knowledge (incidence, survival, and risk factors), lung cancer specific worry, and mental health.

RESULTS:

371 participants completed the questionnaire; 66% (n = 243) had linked clinical data. Perceived absolute risk was markedly higher than calculated risk (median 20% vs. 1%; p < 0.001) and higher in women than men (25% vs. 15%; p = 0.001). There was no correlation between perceived absolute and calculated risk. Overall, 30% classified themselves at higher, and 21% at lower, lung cancer risk compared to others their age. Median PLCOM2012 score increased with perceived comparative risk (p = 0.004). Those eligible for screening were more likely to classify themselves at higher comparative risk (41% vs. 21%; p < 0.0001), report lung cancer-specific worry (27% vs. 10%; p = 0.001) and have indications of depression (20% vs. 10%; p = 0.05). Family history of lung cancer was significantly associated with higher comparative risk (adjOR 4.03, 95%CI 1.74-9.3; p = 0.001).

CONCLUSION:

Employing comparative rather than absolute risk may assist risk counselling. Further research is required to determine the optimal approach to risk communication in this setting.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Detecção Precoce de Câncer / Neoplasias Pulmonares Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Detecção Precoce de Câncer / Neoplasias Pulmonares Idioma: En Ano de publicação: 2022 Tipo de documento: Article